JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.

导出 LinkOut

翻译打印收藏纠错

作者： Azucena,Salas ^[1] ; Cristian,Hernandez-Rocha ^[2] ; Marjolijn,Duijvestein ^[3] ; William,Faubion ^[4] ; Dermot,McGovern ^[5] ; Severine,Vermeire ^[6] ; Stefania,Vetrano ^[7] ; Niels,Vande Casteele ^[8]

作者单位： Department of Gastroenterology, IDIBAPS, Barcelona, Spain. ^[1] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain. ^[2] Zane Cohen Center for Digestive Diseases, Mount Sinai Hospital Inflammatory Bowel Disease Group, Toronto, Ontario, Canada. ^[3] Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands. ^[4] Gastroenterology and Hepatology, Mayo Clinic, Rochester, MI, USA. ^[5] F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. ^[6] Department of Gastroenterology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. ^[7] Department of Biomedical Sciences, Humanitas University, Milan, Italy. ^[8] IBD Center, Laboratory of Immunology in Gastroenterology, Humanitas Clinical and Research Center IRCCS, Milan, Italy. ^[9] Robarts Clinical Trials, London, ON, Canada. nvandecasteele@health.ucsd.edu. ^[10] Department of Medicine, University of California San Diego, La Jolla, CA, USA. nvandecasteele@health.ucsd.edu. ^[11]